Radionetics Oncology

Radionetics Oncology is a clinical-stage radiopharmaceutical company developing potent, small molecule radiopharmaceuticals targeting G-protein coupled receptors for various oncology indications. The company's focus is on revolutionizing cancer treatment through its innovative pipeline. This Series A funding will advance the development of these treatments.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $52.5M

Date: 05-Jan-2024

Investors: Frazier Life Sciences, 5AM Ventures, DCVC Bio, GordonMD ®, Crinetics Pharmaceuticals

Markets: Biotechnology, Radiopharmaceuticals, Oncology

HQ: Menlo Park, California, United States

Founded: 2021

Website: https://radionetics.com/

LinkedIn: https://www.linkedin.com/company/radionetics-oncology

Twitter:

Instagram: